CME Group Cash Flow Statement
CME / Financials|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
CME Group generated $4.3B in operating cash flow and $4.2B in free cash flow in FY2025. Free cash flow margin was 64.3% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $4.1B | $3.5B | $3.2B | $2.7B | $2.6B | $2.0B | $4.1B | $2.0B | $4.1B | $1.5B | $1.2B | $1.1B | $1.8B | $951.4M | $1.8B |
| Depreciation & Amortization | $107.5M | $115.1M | $126.0M | $134.9M | $147.8M | $118.7M | $113.0M | $118.7M | $113.0M | $129.2M | $129.2M | $132.6M | $128.5M | $129.9M | $128.5M |
| Operating Cash Flow | $4.3B | $3.7B | $3.5B | $3.1B | $2.4B | $2.4B | $1.8B | $2.4B | $1.8B | $1.7B | $1.5B | $1.3B | $1.3B | $1.4B | $1.3B |
| Capital Expenditures | $83.5M | $94.0M | $76.4M | $89.7M | $127.2M | $116.7M | $81.9M | $116.7M | $81.9M | $91.8M | $114.2M | $140.7M | $172.2M | $160.0M | $172.2M |
| Free Cash Flow | $4.2B | $3.6B | $3.4B | $3.0B | $2.3B | $2.3B | $1.7B | $2.3B | $1.7B | $1.6B | $1.4B | $1.2B | $1.2B | $1.2B | $1.2B |
| Share Buybacks | - | - | - | - | - | - | - | - | - | - | - | - | $220.4M | $575.3M | $220.4M |
| Dividends Paid | $3.9B | $3.6B | $3.2B | $2.6B | $2.2B | $2.1B | $2.0B | $2.1B | $2.0B | $1.8B | $1.3B | $1.5B | $372.8M | $305.3M | $372.8M |
| FCF Margin | 64.3% | 58.7% | 60.5% | 59.1% | 48.5% | 53.9% | 45.8% | 53.9% | 45.8% | 45.6% | 42.6% | 37.0% | 35.8% | 39.9% | 35.8% |